Casale, T. B., Gimenez-Arnau, A. M., Bernstein, J. A., Holden, M., Zuberbier, T., & Maurer, M. (2023). Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status. Dermatology & Therapy, 13(11), 2573. https://doi.org/10.1007/s13555-023-01040-9
Chicago Style (17th ed.) CitationCasale, Thomas B., Ana Maria Gimenez-Arnau, Jonathan A. Bernstein, Michael Holden, Torsten Zuberbier, and Marcus Maurer. "Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status." Dermatology & Therapy 13, no. 11 (2023): 2573. https://doi.org/10.1007/s13555-023-01040-9.
MLA (9th ed.) CitationCasale, Thomas B., et al. "Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status." Dermatology & Therapy, vol. 13, no. 11, 2023, p. 2573, https://doi.org/10.1007/s13555-023-01040-9.